Dana M. van Bemmel
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Dartmouth College (2012); University of Vermont (2012); Roswell Park Comprehensive Cancer Center (2017); National Institutes of Health (2007–2017); United States Food and Drug Administration (2011–2026); National Institute on Drug Abuse (2017); Maine Medical Center (2012); Medical University of South Carolina (2017); Office of the Director (2011); Maine Medical Center (2012); National Cancer Institute (2011–2017); Division of Cancer Epidemiology and Genetics (2008–2012); Center for Tobacco Products (2011–2025); University of Nebraska Medical Center (2003); Science Applications International Corporation (United States) (2012)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dana M. van Bemmel's research focuses on the assessment of tobacco product use and its associated toxicant exposures within the U.S. population. She has contributed to significant studies, including the design and methodology of the Population Assessment of Tobacco and Health (PATH) Study, which investigates tobacco use patterns and health effects across diverse age groups. Her work also examines specific biomarkers of exposure, such as tobacco-specific nitrosamines (NNAL, NNN, NAT, and NAB), and their relation to health outcomes like renal cell cancer. van Bemmel has analyzed national health survey data to understand nicotine and toxicant exposure among smokeless tobacco users and has investigated changes in biomarkers among smokers transitioning to electronic nicotine delivery systems (ENDS).
Her publications include analyses of tobacco product use by adults and youths, and summaries of workshops focused on biomarkers of potential harm, aiming to inform regulatory actions by agencies like the Food and Drug Administration's Center for Tobacco Products. van Bemmel's research utilizes existing data from large-scale surveys to provide insights into public health challenges related to tobacco consumption. Her scholarship metrics include an h-index of 20, with over 120 publications and more than 2,300 citations.
Metrics
- h-index: 25
- Publications: 131
- Citations: 3,278
Selected Publications
-
Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods (2026)
Collaboration Network
Top Collaborators
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
- Population Assessment of Tobacco and Health (PATH) Study Wave 1 and Wave 4 Biomarker Cores and available biomarker data: design and methods
Similar Researchers
Based on overlapping research topics